Exercise in Persons With Multiple Sclerosis

CompletedNot a drug-phase studyRelapsing MSNCT04944251

What it found

Paper found, not read

A paper reports the results; we have not read it yet. See Papers below.

What was tested

Treatment tested

  • Regular Exercise

What it measured

Main measures

  • Aerobic capacity assessment after exercise intervention

    Each participant's progress will be tested at the beginning and end of the 12-week training period.

    Physical function
  • Strength assessment after exercise intervention

    Each participant's progress will be tested at the beginning and end of the 12-week training period.

    Physical function
  • plasma neurotrophin values (pg/ml)

    Each participant's progress will be tested at the beginning and end of the 12-week training period.

    Physical function

Who could take part

Relapsing MS · 18 to 55

Show the full criteria

Inclusion criteria

* A total of 53 relapsing remitting form MS (RRMS) patients between the ages of 18-55 years, diagnosed with definite MS according to 2017 McDonald criteria, and followed up in Ege University MS and Demyelinating Diseases Unit, without an MS attack in the last 3 months, had an EDSS score ≤ 4 that did not change with symptomatic or immunomodulatory treatments within 6 months were included in this prospective randomized controlled study.

Exclusion criteria

* Patients who did not meet the inclusion criteria were excluded from the study.

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

ABSTRACT Objective: The investigators aimed to determine the effect of regular exercise on aerobic capacity, strength values, and plasma levels of nerve growth factor (NGF) and Neurotrophin-3 (NT-3) in patients with multiple sclerosis (MS), and investigate its effects on MS symptoms including cognitive impairment, fatigue, balance disorders and quality of life. Methods: Forty-three relapsing-remitting MS (RRMS) patients with an EDSS score of 4 or less participated in the study. Participants were divided into 3 groups as aerobic exercise, strength exercise and control groups. The patients in the exercise groups had exercise programs 3 days a week, for 3 months. Aerobic capacity (maximum VO2 value), strength measurements and balance tests were done, and NGF and NT-3 plasma levels were analyzed in all participants at the beginning and end of the study. MSQoL54 quality of life, fatigue impact scale (FIS), Pittsburgh Sleep Quality Index (PSQI) and BICAMS scale were applied to evaluate cognitive functions.

Papers

Loading reviews and guidelines…

History

    1. Started

      Apr 2019

    2. Main results due

      Dec 2019

    3. Finished

      Jan 2020

    Assembled by software from public sources.